|
Inovio Pharmaceuticals (formerly Genetronics), specializes in developing technology and hardware that has the potential to allow physicians to more efficiently and cost-effectively deliver life-saving drugs or beneficial genes to patients with catastrophic illnesses, including cancer. The company is the technology leader in electroporation therapy (EPT), the application of very brief, carefully controlled, pulsed electric fields, to human cells. This process causes pores to open in the cell membrane and allows pharmaceuticals or genes, injected in the area prior to the application of the electric pulse, to gain access to the cell's interior. The cell pores close up a short time later, trapping the chemotherapeutic agents inside the cancer cell, so they can destroy the cell
|
|
|||||||||||||||||||
|
|
||||||||||||||||||||
|
||||||||||||||||||||
